Eikon Therapeutics
Eikon Therapeutics is developing a new method of drug discovery based on tracking and measuring the movement of individual proteins in live cells.
2
Funding Rounds
$666.0m
Money raised
Funding
Funding series
Funding Series Analysis
The company Eikon Therapeutics has raised a total of $666m in funding over 2 rounds.
Key Insights:
- Eikon Therapeutics Series B round, January 2022: $518m
- Eikon Therapeutics Series A round, May 2021: $148m
Eikon Therapeutics Series B round, January 2022
$518m
Eikon Therapeutics Series A round, May 2021
$148m
Industries
Eikon Therapeutics is active in the following industries:
- Single-cell analysis
- Biomedical engineering
- Synthetic chemistry
- Engineering
- Biotechnology
- Cell biology